There are 2789 resources available
14P - Preclinical evaluation of intermittent dosing regimens on antitumor and PD activity of SY-5609, a potent and selective oral CDK7 inhibitor, in ovarian cancer xenografts
Presenter: Liv Johannessen
Session: ePoster Display
15P - Modified sialoglycan by neuraminidase promotes tumor immunity against epithelial ovarian cancer
Presenter: Huang mei
Session: ePoster Display
16P - Repurposing rosiglitazone with chemotherapy in breast cancer: A sequence-specific synergy?
Presenter: Sally Al-Moualem
Session: ePoster Display
17P - PD-1 and LAG-3 immune checkpoints constitutive activators exhibit differential expression phenotypes
Presenter: Luisa Chocarro
Session: ePoster Display
18P - In vitro analysis of the combination of APR-246 and carboplatin in triple negative breast cancer (TNBC) and high grade serous ovarian cancer (HGSOC) cell lines and its impact on Aurora kinase A (AURKA)-p53 pathway
Presenter: Juan Jose Martinez-Pretel
Session: ePoster Display
19P - Evaluation of different pharmacokinetic-pharmacodynamic models for tumor growth delay prediction after chemotherapy
Presenter: Ivan Terterov
Session: ePoster Display
20P - Molecular mechanism of MK2-CRABP2 signaling pathway mediating the progression of lung adenocarcinoma
Presenter: Jianxiong Deng
Session: ePoster Display
21P - Analysis of germline variants in the immune response-related genes in BRCA1 mutation carriers: Possible modifying effect on age-dependent BRCA1 penetrance
Presenter: Ekaterina Kuligina
Session: ePoster Display
22P - Functional characterization of DIRC3 long non-coding RNA in differentiated thyroid cancer
Presenter: Piotr Tomasz Wysocki
Session: ePoster Display
23P - Transcriptional profiling of circulating tumor and hybrid cells in breast cancer patients
Presenter: Evgeny Denisov
Session: ePoster Display
Resources:
Abstract